Alector, Inc. current report, 22 September 2022

Business Context and Reporting Period

This Form 8-K is a current report filed by Alector, Inc. on September 22, 2022. The filing addresses corporate governance and equity incentive matters rather than periodic financial performance.

Key Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on the amendment of an equity incentive plan.

Material Changes

The Board of Directors approved an amendment to the 2022 Inducement Equity Incentive Plan with the following material change:

  • Share Increase: The number of shares available for issuance under the plan was increased from 1,630,000 to 3,300,000 shares.
  • Approval Method: The amendment was adopted without stockholder approval pursuant to applicable Nasdaq Listing Rules.

Guidance, Outlook, and Management Commentary

The filing contains no financial guidance, outlook, or management commentary regarding business operations. Key details regarding the plan include:

  • Eligibility: Awards are restricted to individuals not previously employed by the Company (or those with a bona fide period of non-employment) as an inducement material to their entry into employment, or in connection with a merger or acquisition.
  • Award Types: The plan permits nonstatutory stock options, restricted stock units, restricted stock, stock appreciation rights, performance shares, and performance units.
  • Terms: Terms are substantially similar to the Company's 2019 Equity Incentive Plan, including treatment of awards during a merger or change in control.

Investor Verification Checklist

  • Verify the total number of shares authorized under the amended 2022 Inducement Plan (3,300,000).
  • Confirm that the amendment was executed under the Nasdaq inducement award exception without shareholder vote.
  • Review Exhibit 10.1 for the full text of the amended plan and specific award agreement forms.
  • Check subsequent filings for actual grants made under this expanded plan to assess dilution impact.